诺华公布，第一季度净销售额同比增长15%至132亿美元，高于分析师普遍预期的131.2亿美元。经调整后核心营业利润达55.8亿美元，同比增长27%，亦高于市场预期的50.7亿美元。
展望未来，诺华制药将2025年全年净销售额增长指引从中高个位数上调至高个位数，核心营业利润增长指引从高个位数至低双位数调整为低双位数。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.